Problems with mental processing speed are common among people at high risk for psychosis, and are thought to be related to broader deficits in social functioning. In a new clinical trial, researchers…
Read More
A 2015 study comparing schizophrenia patients who received oral or injectable antipsychotic medications found no difference in relapse rates between the groups. Now, a follow-up study published…
Read More
Insomnia is a common complaint among people who go on to develop schizophrenia or other psychotic disorders, as well among people who are considered at high risk for these disorders but…
Read More
An authoritative new study finds that cognitive problems experienced by people with schizophrenia, such as problems with attention and memory, are present in the early stage of the disorder, before…
Read More
In a schizophrenia-related disorder known as 22q11.2 deletion syndrome (22q11DS), altered activity along a single molecular pathway can lead to disruptions in neural connections in the brain that…
Read More
